Nasdaq-listed biotech firm Sonnet BioTherapeutics has announced a significant strategic shift, forming a business combination with Rorschach to establish Hyperliquid Strategies Inc. (HSI).
Read MoreNasdaq-listed biotech firm Sonnet BioTherapeutics has announced a significant strategic shift, forming a business combination with Rorschach to establish Hyperliquid Strategies Inc. (HSI).
Read MoreWith Bitcoin (BTC) recently achieving a new all-time high, attention is now turning to Hyperliquid’s native token, HYPE, which appears to be on the cusp of reaching its own record peak.
Read MoreHyperliquid has introduced a staking mechanism for its native HYPE token, allowing holders to actively participate in securing the network and earn rewards.
Read MoreHyperliquid's HYPE token has been on a meteoric rise since its token generation event (TGE) on Friday, November 30th.
Read More